Latest stories on TSHA
Taysha Gene Therapies (TSHA) is One of The Most Affordable Biotech Names to Invest In
Yahoo Finance56 · neutralanalyst
Taysha's R&D Chief Sold $1.2 Million in Stock After a 149% Run
Yahoo Finance42 · neutralgeneral
Taysha's R&D Chief Sold $1.2 Million in Stock After a 149% Run
The Motley Fool42 · neutralgeneral
Taysha: 'Buy' On Interim Analysis Of TSHA-102 First Half 2027 And Broad Label Potential
Seeking Alpha67 · bullishproduct/pr
Taysha Gene Therapies, Inc. (TSHA) files 8-K
SEC 8-K50 · neutralgeneral
Taysha Gene Therapies shares tumble following pricing shares at $6.00 to raise $200M
Seeking Alpha24 · bearishgeneral
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants | TSHA Stock News
StockTitan24 · bearishgeneral
Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants | TSHA Stock News
StockTitan24 · bearishgeneral
Taysha Gene Therapies, Inc. (TSHA) Discusses Longer-Term Clinical Data and Program Update for TSHA-102 in Rett Syndrome - Slideshow
Seeking Alpha55 · neutralproduct/pr
Taysha Gene Therapies, Inc. (TSHA) Discusses Longer-Term Clinical Data and Program Update for TSHA-102 in Rett Syndrome Transcript
Seeking Alpha56 · neutralproduct/pr
Taysha Completes REVEAL Dosing, Advances Rett Gene Therapy
TipRanks63 · neutralproduct/pr
Taysha Gene Therapies, Inc. (TSHA) files 8-K
SEC 8-K50 · neutralgeneral
Is Taysha Gene Therapies, Inc. (TSHA) A Good Stock To Buy Now?
Yahoo Top57 · neutralanalyst
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | TSHA Stock News
StockTitan50 · neutralgeneral
Taysha Gene Therapies: Shortened Timeline Increases The Potential
Seeking Alpha67 · bullishanalyst
Taysha Gene Therapies (TSHA) Reports Financial Results for Q1 2026
Yahoo Top56 · neutralearnings
Canaccord Keeps Buy Rating on Taysha (TSHA) After Q1 Highlights
Yahoo Finance61 · neutralanalyst